Apr 30, 2013 (BUSINESS WIRE) -- Octapharma USA requests that their press release NewsItemId: 20130429006142 issued April 29, 2013, entitled "FDA Accepts Octapharma USA Biological License Application for octaplex(R) - an Investigational 4-Factor PCC" be killed.

The release was issued prematurely by Octapharma USA and contains inaccuracies.

http://cts.businesswire.com/ct/CT?id=bwnews&sty=20130429006142r2&sid=cmtx4&distro=nx

Glta

Stockman6767